新希望(000876.SZ)擬建設湖南郴州年出欄30萬頭生豬養殖項目 項目總投資額約5.8億元
格隆匯 2 月 9日丨新希望(000876.SZ)公佈,公司召開第八屆董事會第三十次會議,審議通過了“關於繼續加大生豬養殖投資的議案”。
為落實公司生豬產業發展戰略,促進公司養殖業務的發展,公司擬繼續加大在生豬養殖業務的投資力度,擬建設湖南郴州年出欄30萬頭生豬養殖項目,項目總投資額共計約5.8億元,其中固定資產投資共計約4.12億元,生物性資產和流動資金投資共計1.68億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.